• No se han encontrado resultados

OPTIMIZACÍON DEL TRATAMIENTO DE LA INSUFICIENCIA CARDÍACA

N/A
N/A
Protected

Academic year: 2019

Share "OPTIMIZACÍON DEL TRATAMIENTO DE LA INSUFICIENCIA CARDÍACA"

Copied!
152
0
0

Texto completo

Loading

Referencias

Documento similar

La hipercolesterolemia familiar (HF) una enfermedad hereditaria de transmisión autosómica dominante que se manifiesta desde el nacimiento. Es conocida también como

Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia

Given the predictive power of our procedure, it is interesting to check whether the IBM Hamiltonian determined from the microscopic mean-field calculation can explain the

The findings of our study suggest that chronic recurrent stage, recurrent episodes of uveitis, angle closure disease, and peripapillary atrophy are all significant risk factors for

The main hypothesis of the SPHERE-HF ( b 3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure) trial is that maintenance treatment with

Therefore, the main aim of this study was to analyze the differential impact of a SFA-enriched HF diet and a MUFA-enriched HF diet on endothelial function, vascular remodeling and

Los pacientes con insuficiencia cardíaca tienen un riesgo mayor de hipotensión por lo que, cuando se inicia el tratamiento con un inhibidor de la ECA, se recomienda una dosis

For these patients and their families, heart transplantation is not just a simple surgery aimed at the quality of life of people with heart failure (HF), but a procedure